{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:02:10Z","timestamp":1789506130230,"version":"build-2803163510"},"reference-count":216,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.numecd.2025.104409","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T23:01:48Z","timestamp":1760396508000},"page":"104409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies"],"prefix":"10.1016","volume":"36","author":[{"given":"Rita Cristina Myriam","family":"Intravaia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tognola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2612-6264","authenticated-orcid":false,"given":"Alessandro","family":"Maloberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Brucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Campione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Giannattasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mojoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio Giuseppe","family":"Abrignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Temporelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.numecd.2025.104409_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","article-title":"Inflammation, aging, and cardiovascular disease: JACC review topic of the week","volume":"79","author":"Liberale","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation","volume":"126","author":"Mouton","year":"2020","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.numecd.2025.104409_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13453","article-title":"Chronic low-grade inflammation in heart failure with preserved ejection fraction","volume":"20","author":"Mesquita","year":"2021","journal-title":"Aging Cell"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10654-011-9565-6","article-title":"Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study","volume":"26","author":"Adamsson Eryd","year":"2011","journal-title":"Eur J Epidemiol"},{"issue":"9","key":"10.1016\/j.numecd.2025.104409_bib5","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.3390\/ijms24097910","article-title":"Atherosclerosis and inflammation: insights from the theory of general pathological processes","volume":"24","author":"Gusev","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2025.104409_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115108","article-title":"Cardiovascular risk factors and molecular routes underlying endothelial dysfunction: novel opportunities for primary prevention","volume":"202","author":"Benincasa","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.numecd.2025.104409_bib7","series-title":"Endotext [Internet]","article-title":"The role of lipids and lipoproteins in atherosclerosis. 2019 Jan 3","author":"Linton","year":"2000"},{"issue":"24","key":"10.1016\/j.numecd.2025.104409_bib8","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.3390\/cells11244060","article-title":"Vascular smooth muscle cells phenotypic switching in cardiovascular diseases","volume":"11","author":"Tang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.numecd.2025.104409_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.845942","article-title":"Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms","volume":"9","author":"Gui","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104409_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.613780","article-title":"Overview of OxLDL and its impact on cardiovascular health: focus on atherosclerosis","volume":"11","author":"Poznyak","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.numecd.2025.104409_bib11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.numecd.2025.104409_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11538-024-01333-w","article-title":"A lipid-structured model of atherosclerosis with macrophage proliferation","volume":"86","author":"Chambers","year":"2024","journal-title":"Bull Math Biol"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.numecd.2025.104409_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-Reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11739-007-0076-0","article-title":"CD40\/CD40L system and vascular disease","volume":"2","author":"Santilli","year":"2007","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2741\/s508","article-title":"Inflammatory biomarkers of coronary heart disease","volume":"10","author":"Li","year":"2018","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.numecd.2025.104409_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cytogfr.2014.01.005","article-title":"Role of calprotectin in cardiometabolic diseases","volume":"25","author":"Kruzliak","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.numecd.2025.104409_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pharmthera.2017.08.015","article-title":"The role of osteoprotegerin in the crosstalk between vessels and bone: its potential utility as a marker of cardiometabolic diseases","volume":"182","author":"Rochette","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138161211795049804","article-title":"Mean platelet volume: a link between thrombosis and inflammation?","volume":"17","author":"Gasparyan","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/stem.5530080414","article-title":"The control of megakaryocyte ploidy and platelet production: biology and pathology","volume":"8","author":"Gladwin","year":"1990","journal-title":"Int J Cell Cloning"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2257.1992.tb00103.x","article-title":"Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis","volume":"14","author":"Kario","year":"1992","journal-title":"Clin Lab Haematol"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/jcm12031128","article-title":"Systemic immune inflammation index (SII), System Inflammation Response Index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-Year Follow-Up cohort Study of 42,875 US adults","volume":"12","author":"Xia","year":"2023","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1076029615569568","article-title":"The relation between atherosclerosis and the neutrophil-lymphocyte ratio","volume":"22","author":"Balta","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"issue":"7","key":"10.1016\/j.numecd.2025.104409_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/09537104.2014.979340","article-title":"The platelet-lymphocyte ratio: a simple, inexpensive and rapid prognostic marker for cardiovascular events","volume":"26","author":"Balta","year":"2015","journal-title":"Platelets"},{"issue":"41","key":"10.1016\/j.numecd.2025.104409_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035363","article-title":"High CRP-albumin ratio is associated high thrombus burden in patients with newly diagnosed STEMI","volume":"102","author":"Kaplangoray","year":"2023","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib27","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12872-023-03472-9","article-title":"The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with chronic heart failure","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"issue":"19","key":"10.1016\/j.numecd.2025.104409_bib28","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/01.CIR.102.19.2329","article-title":"Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy","volume":"102","author":"Barron","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0003319711407304","article-title":"Relationship between white blood cell count and in-hospital outcomes in acute coronary syndrome patients from the Middle East","volume":"63","author":"Sulaiman","year":"2012","journal-title":"Angiology"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0735-1097(02)02484-1","volume":"40","author":"Sabatine","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2362.2009.02107.x","article-title":"Significance of white blood cell count and its subtypes in patients with acute coronary syndrome","volume":"39","author":"Huang","year":"2009","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9149(00)01444-2","article-title":"Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 investigators","volume":"87","author":"Cannon","year":"2001","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.numecd.2025.104409_bib33","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/medicina60122101","article-title":"Prognostic role of neutrophil percentage-to-albumin ratio in patients with Non-ST-Elevation myocardial infarction","volume":"60","author":"Karaca","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib34","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0735-1097(01)01613-8","article-title":"The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project","volume":"38","author":"Barron","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.numecd.2025.104409_bib35","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/eurheartj\/ehl191","article-title":"Significance of total and differential leucocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty","volume":"27","author":"Mariani","year":"2006","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12928","article-title":"Usefulness of the C-Reactive Protein\/Albumin Ratio for predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"48","author":"Karaba\u011f","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.numecd.2025.104409_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2350-5-13","article-title":"Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes","volume":"5","author":"Byrne","year":"2004","journal-title":"BMC Med Genet"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib38","first-page":"178","article-title":"Predictive value of plasma fibrinogen levels in patients admitted for acute coronary syndrome","volume":"37","author":"Shi","year":"2010","journal-title":"Tex Heart Inst J"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib39","first-page":"2972","article-title":"Prognostic value of fibrinogen-to-albumin ratio in predicting 1-year clinical progression in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention","volume":"18","author":"He","year":"2019","journal-title":"Exp Ther Med"},{"issue":"12","key":"10.1016\/j.numecd.2025.104409_bib40","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1161\/01.CIR.96.12.4204","article-title":"Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"96","author":"Toss","year":"1997","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0735-1097(99)00007-8","article-title":"A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study","volume":"33","author":"Ma","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib42","article-title":"Correlation of fibrinogen levels with acute myocardial infarction risk in the Chinese Han population","volume":"15","author":"Xu","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.numecd.2025.104409_bib43","first-page":"1047","article-title":"Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes","volume":"44","author":"Abrignani","year":"1999","journal-title":"Cardiologia"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12933-019-0858-5","article-title":"Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study","volume":"18","author":"Zhang","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/MCA.0000000000000789","article-title":"Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention","volume":"31","author":"Song","year":"2020","journal-title":"Coron Artery Dis"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2796.2003.01181.x","article-title":"Prognostic value of plasma C-reactive protein and fibrinogen determinations in patients with acute myocardial infarction treated with thrombolysis","volume":"254","author":"Bennermo","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2025.104409_bib47","article-title":"Prognostic potential of inflammatory markers in chronic kidney disease patients combined with acute myocardial infarction","volume":"11","author":"Dang","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104409_bib48","article-title":"Prognostic role of high sensitivity C-Reactive protein in patients with acute myocardial infarction","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104409_bib49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/VHRM.S198452","article-title":"Predictive value of high sensitivity C-reactive protein on progression to heart failure occurring after the first myocardial infarction","volume":"15","author":"Al","year":"2019","journal-title":"Vasc Health Risk Manag"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijcard.2005.06.021","article-title":"C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings","volume":"109","author":"Brunetti","year":"2006","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/26324636211055370","article-title":"On-admission serum high-sensitivity C-Reactive protein level independently predicts In-Hospital mortality and adverse cardiovascular events in ST-elevation acute myocardial infarction","volume":"3","author":"Hartopo","year":"2021","journal-title":"Indian Journal of Clinical Cardiology"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/00045632211004651","article-title":"Comparison of high-sensitivity C-reactive protein vs. C-reactive protein for diagnostic accuracy and prediction of mortality in patients with acute myocardial infarction","volume":"58","author":"Hofer","year":"2021","journal-title":"Ann Clin Biochem"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.003103","article-title":"Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study","volume":"2","author":"Zamani","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIRCULATIONAHA.106.628909","article-title":"Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the aggrastat-to-zocor Trial","volume":"114","author":"Morrow","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.numecd.2025.104409_bib55","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.3390\/jcm11092453","article-title":"Early detection of inflammation-prone STEMI patients using the CRP Troponin Test (CTT)","volume":"11","author":"Brzezinski","year":"2022","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib56","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0735-1097(02)02969-8","article-title":"Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy","volume":"41","author":"James","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12872-025-04608-9","article-title":"Markers of inflammation predicts long-term mortality in patients with acute coronary syndrome - a cohort study","volume":"25","author":"Odeberg","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib58","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.3892\/etm.2016.3882","article-title":"Clinical and angiographic correlation of high-sensitivity C-reactive protein with acute ST elevation myocardial infarction","volume":"12","author":"Tanveer","year":"2016","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/clc.70090","article-title":"A biomarker-based scoring System to assess the presence of obstructive coronary artery disease in patients with myocardial infarction","volume":"48","author":"Espinosa Pascual","year":"2025","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12933-020-01157-7","article-title":"Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus","volume":"19","author":"Lucci","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib61","first-page":"694","article-title":"TNF-\u03b1 and E-Selectin as valuable biomarkers in patients with acute coronary artery syndrome","volume":"14","author":"Auda","year":"2025","journal-title":"Int J Mol Cell Med"},{"issue":"18","key":"10.1016\/j.numecd.2025.104409_bib62","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.101.18.2149","article-title":"Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.numecd.2025.104409_bib63","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/diagnostics15081033","article-title":"Endothelial function and pro-inflammatory cytokines as prognostic markers in acute coronary syndromes","volume":"15","author":"Tsalamandris","year":"2025","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.numecd.2025.104409_bib64","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000155614.35441.69","article-title":"Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study","volume":"111","author":"Valgimigli","year":"2005","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.numecd.2025.104409_bib65","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","article-title":"CAPTURE Study Investigators. Soluble CD40 ligand in acute coronary syndromes","volume":"348","author":"Heeschen","year":"2003","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.numecd.2025.104409_bib66","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.CIR.0000088521.04017.13","article-title":"Soluble CD40L: risk prediction after acute coronary syndromes","volume":"108","author":"Varo","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.numecd.2025.104409_bib67","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehn071","article-title":"Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18","volume":"29","author":"Morrow","year":"2008","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib68","first-page":"82","article-title":"Association between levels of circulating soluble CD40 ligand on admission and in-hospital events among acute coronary syndrome patients","volume":"43","author":"Setianto","year":"2011","journal-title":"Acta Med Indones"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib69","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cyto.2013.03.020","article-title":"IL-6 and its receptors in coronary artery disease and acute myocardial infarction","volume":"62","author":"Anderson","year":"2013","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib70","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001869","article-title":"High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI","volume":"8","author":"T\u00f8llefsen","year":"2021","journal-title":"Open Heart"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib71","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005637","article-title":"Interleukin-6 and the risk of adverse outcomes in patients after an acute coronary syndrome: observations from the SOLID-TIMI 52 (stabilization of plaque using Darapladib-Thrombolysis in myocardial infarction 52) trial","volume":"6","author":"Fanola","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2025.104409_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106806","article-title":"Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome","volume":"135","author":"Gager","year":"2020","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.numecd.2025.104409_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156696","article-title":"Inflammatory biomarkers and long-term outcome in young patients three months after a first myocardial infarction","volume":"182","author":"Cederstr\u00f6m","year":"2024","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib74","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/diagnostics15101211","article-title":"Integrating the interleukins in the biomarker Panel for the diagnosis and prognosis of patients with acute coronary syndromes: unraveling a multifaceted conundrum","volume":"15","author":"Timpau","year":"2025","journal-title":"Diagnostics"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib75","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/ATVBAHA.109.202697","article-title":"Interleukin-18 as a predictor of future events in patients with acute coronary syndromes","volume":"30","author":"Hartford","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24229","article-title":"Prognostic significance of IL-18 in acute coronary syndrome patients","volume":"47","author":"Xiong","year":"2024","journal-title":"Clin Cardiol"},{"issue":"12","key":"10.1016\/j.numecd.2025.104409_bib77","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/clc.23274","article-title":"Interleukin-18 in patients with acute coronary syndromes","volume":"42","author":"\u00c5kerblom","year":"2019","journal-title":"Clin Cardiol"},{"issue":"20","key":"10.1016\/j.numecd.2025.104409_bib78","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000099509.76044.A2","article-title":"Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"108","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib79","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1253\/circj.71.703","article-title":"Level and value of interleukin-18 in patients with acute myocardial infarction undergoing primary coronary angioplasty","volume":"71","author":"Youssef","year":"2007","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1536\/ihj.51.75","article-title":"Interleukin-18 levels on admission are associated with mid-term adverse clinical events in patients with ST-segment elevation acute myocardial infarction undergoing percutaneous coronary intervention","volume":"51","author":"Gao","year":"2010","journal-title":"Int Heart J"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/CS20050058","article-title":"Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction","volume":"109","author":"Crisafulli","year":"2005","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib82","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2459\/JCM.0b013e3283561433","article-title":"Serum osteoprotegerin and carotid intima-media thickness in acute\/chronic coronary artery diseases","volume":"14","author":"Ciccone","year":"2013","journal-title":"J Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib83","first-page":"1","article-title":"The role of the osteoprotegerin\/RANKL\/RANK axis and osteopontin in acute coronary syndrome","volume":"95","author":"Vega-Rosales","year":"2024","journal-title":"Arch Cardiol Mex"},{"issue":"19","key":"10.1016\/j.numecd.2025.104409_bib84","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.3390\/jcm10194326","article-title":"Association between Serum osteoprotegerin levels and severity of coronary artery disease in patients with acute myocardial infarction","volume":"10","author":"Cottin","year":"2021","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib85","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/heartjnl-2011-301260","article-title":"Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes","volume":"98","author":"R\u00f8ysland","year":"2012","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib86","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jacc.2004.06.076","article-title":"Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction","volume":"44","author":"Ueland","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib87","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2007.09.058","article-title":"Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes","volume":"51","author":"Omland","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib88","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007009","volume":"7","author":"Ueland","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib89","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12872-020-01717-5","article-title":"Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome","volume":"20","author":"Song","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.numecd.2025.104409_bib90","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/abr.abr_438_23","article-title":"Calprotectin correlates with reduced level of LVEF and occurrence of cardiac arrhythmia in STEMI patients","volume":"13","author":"Haybar","year":"2024","journal-title":"Adv Biomed Res"},{"issue":"33","key":"10.1016\/j.numecd.2025.104409_bib91","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020805","article-title":"Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a Cohort study","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"8","key":"10.1016\/j.numecd.2025.104409_bib92","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/1076029616683804","article-title":"Platelet count and mean platelet volume at the time of and after acute myocardial infarction","volume":"23","author":"Amraotkar","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib93","first-page":"563","article-title":"Impact of platelet volume on the clinical outcomes of patients with acute coronary syndrome","volume":"35","author":"Chang","year":"2019","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.numecd.2025.104409_bib94","article-title":"Study of mean platelet volume in acute coronary syndrome","author":"Prasanth Kumar","year":"2020","journal-title":"JMSCR"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib95","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.amjcard.2016.09.042","article-title":"Usefulness of mean platelet volume to predict significant coronary artery disease in patients with Non-ST-Elevation acute coronary syndromes","volume":"119","author":"Taskesen","year":"2017","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib96","first-page":"1005","article-title":"Analysis of platelet morphological parameters as clinical risk stratification in acute coronary syndrome","volume":"105","author":"Zhang","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib97","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12872-019-1115-2","article-title":"Mean platelet volume and coronary plaque vulnerability: an optical coherence tomography study in patients with non-ST-elevation acute coronary syndrome","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib98","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jacc.2005.03.065","article-title":"Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention","volume":"46","author":"Huczek","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib99","first-page":"132","article-title":"Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome","volume":"106","author":"Taglieri","year":"2011","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib100","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.62347\/OYHQ5176","article-title":"Prognostic value of mean platelet volume and platelet distribution width for the outcomes of patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention","volume":"17","author":"He","year":"2025","journal-title":"Am J Transl Res"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib101","article-title":"Mean platelet volume and its Association with In-Hospital outcomes in patients with acute ST-Segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"16","author":"Ekmekci","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.amjcard.2012.09.014","article-title":"Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention","volume":"111","author":"Shah","year":"2013","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib103","first-page":"333","article-title":"The relationship between neutrophil percentage-to-albumin ratio and infarct related artery patency in patients with acute coronary syndrome","volume":"8","author":"Akg\u00fcm\u00fc\u015f","year":"2025","journal-title":"J Health Sci Med\/JHSM"},{"key":"10.1016\/j.numecd.2025.104409_bib104","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.12659\/MSM.917987","article-title":"The neutrophil percentage to albumin ratio as a new predictor of In-Hospital mortality in patients with ST-Segment elevation myocardial infarction","volume":"25","author":"Cui","year":"2019","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12872-022-02559-z","article-title":"The neutrophil percentage-to-albumin ratio is associated with all-cause mortality in critically ill patients with acute myocardial infarction","volume":"22","author":"Lin","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.numecd.2025.104409_bib106","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.2147\/JIR.S528161","article-title":"Prognostic role of inflammatory hematologic indices in predicting acute coronary syndrome in elderly patients with chronic coronary syndrome","volume":"18","author":"Bao","year":"2025","journal-title":"J Inflamm Res"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib107","first-page":"14","article-title":"Systemic immune-inflammation index predicts major cardiovascular adverse events in patients with ST-Segment elevated myocardial infarction","volume":"119","author":"Saylik","year":"2022","journal-title":"Arq Bras Cardiol"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib108","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211016274","article-title":"Systemic immune-inflammation index as a promising predictor of mortality in patients with acute coronary syndrome: a real-world study","volume":"49","author":"Su","year":"2021","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib109","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12865-025-00690-y","article-title":"Association of the systemic immune-inflammation index with clinical outcomes in acute myocardial infarction patients with hypertension","volume":"26","author":"Zheng","year":"2025","journal-title":"BMC Immunol"},{"key":"10.1016\/j.numecd.2025.104409_bib110","article-title":"Relationship between inflammatory markers and long-term prognosis in ICU patients with acute non-ST-segment elevation myocardial infarction","volume":"12","author":"Li","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib111","first-page":"116","article-title":"Risk stratification in acute coronary syndromes: the systemic immune-inflammation index as Prognostic marker","volume":"13","author":"Babes","year":"2025","journal-title":"Med Sci"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib112","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s12872-025-04990-4","article-title":"Prognostic value of systemic immune-inflammatory index in patients with diabetes mellitus and acute coronary syndrome after percutaneous coronary intervention: a prospective cohort study","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.numecd.2025.104409_bib113","doi-asserted-by":"crossref","DOI":"10.1007\/s11739-025-04018-x","article-title":"Comparison of the prognostic value of complete blood count-derived inflammatory markers for long-term outcomes in ST-segment elevation myocardial infarction","author":"Ting","year":"2025","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.numecd.2025.104409_bib114","article-title":"SII as a predictor of mortality in patients with non-ST-segment elevation myocardial infarction and diabetes mellitus","volume":"45","author":"Huang","year":"2025","journal-title":"Pract Lab Med"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib115","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/MCA.0000000000001496","article-title":"Prognostic value of systemic immune-inflammation index in older patients with acute coronary syndrome","volume":"36","author":"G\u00fcrdal","year":"2025","journal-title":"Coron Artery Dis"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib116","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12291-024-01188-x","article-title":"Predictive value of lymphocyte based indices to determine major adverse cardiovascular events in acute coronary syndrome undergoing percutaneous coronary intervention","volume":"40","author":"Mohanty","year":"2025","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.numecd.2025.104409_bib117","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2147\/JIR.S443153","article-title":"A prediction model based on systemic immune-inflammatory index combined with other predictors for major adverse cardiovascular events in acute myocardial infarction patients","volume":"17","author":"Li","year":"2024","journal-title":"J Inflamm Res"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-024-02129-x","article-title":"Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry","volume":"23","author":"Luo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2025.104409_bib119","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.2147\/JIR.S435398","article-title":"The systemic inflammation index predicts poor clinical prognosis in patients with initially diagnosed acute coronary syndrome undergoing primary coronary angiography","volume":"16","author":"Gao","year":"2023","journal-title":"J Inflamm Res"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.31083\/j.rcm2510382","article-title":"Association between Systemic Immune-Inflammation Index (SII) and new-onset In-Hospital heart failure in patients with STEMI after primary PCI","volume":"25","author":"Wang","year":"2024","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib121","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12872-025-04480-7","article-title":"Prognosis modelling of adverse events for post-PCI treated AMI patients based on inflammation and nutrition indexes","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.numecd.2025.104409_bib122","volume":"12","author":"Luo","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib123","article-title":"Integration of hematologic and metabolic biomarkers for outcome prediction in acute coronary syndromes without ST elevation","volume":"17","author":"Becirovic","year":"2025","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib124","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/diagnostics15101191","article-title":"Inflammatory biomarkers predicting contrast-induced acute kidney injury in elderly patients with ST-Segment elevation myocardial infarction","volume":"15","author":"Yildiz","year":"2025","journal-title":"Diagnostics"},{"issue":"52","key":"10.1016\/j.numecd.2025.104409_bib125","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041094","article-title":"The progression of non-culprit coronary lesion is related to higher SII, SIRI, and PIV in patients with ACS","volume":"103","author":"Yilu","year":"2024","journal-title":"Medicine (Baltim)"},{"issue":"12","key":"10.1016\/j.numecd.2025.104409_bib126","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.3390\/jcm14124283","article-title":"Inflammatory indices in patients with myocardial infarction complicated by cardiogenic shock, and their interconnections with SCAI stages and patients' survival: a retrospective Study","volume":"14","author":"Kologrivova","year":"2025","journal-title":"J Clin Med"},{"issue":"20","key":"10.1016\/j.numecd.2025.104409_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39029","article-title":"The predictive role of Systemic Inflammation Response Index (SIRI), Neutrophil-Lymphocyte Ratio (NLR), and Platelet-Lymphocyte Ratio (PLR) in the prognosis of acute coronary syndrome in a tertiary care hospital","volume":"10","author":"Rajakumar","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.numecd.2025.104409_bib128","first-page":"109","article-title":"The Association of neutrophil to lymphocyte ratio and other complete blood count parameters with global registry of acute coronary events risk Score in patients with Non-ST segment elevation - acute coronary syndrome: a single-center Study","volume":"38","author":"Abduljabbar","year":"2024","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.numecd.2025.104409_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1469730","article-title":"The correlation between serum MHR and NLR and the severity of coronary lesions in NSTE-ACS patients of different genders","volume":"11","author":"Yang","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib130","article-title":"Association between mild renal insufficiency, inflammatory status on initial admission, and 1-year mortality following ST-segment elevation myocardial infarction","volume":"15","author":"Luo","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104409_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1439650","article-title":"Prognostic value of inflammatory markers for all-cause mortality in patients with acute myocardial infarction in the coronary care unit: a retrospective study based on MIMIC-IV database","volume":"12","author":"Cao","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib132","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5603\/CJ.a2013.0148","article-title":"Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction","volume":"21","author":"Sawant","year":"2014","journal-title":"Cardiol J"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib133","article-title":"The neutrophil-lymphocyte ratio to predict poor prognosis of critical acute myocardial infarction patients: a retrospective cohort study","volume":"33","author":"Wang","year":"2023","journal-title":"Biochem Med"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib134","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2007.11.004","article-title":"Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction","volume":"101","author":"N\u00fa\u00f1ez","year":"2008","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib135","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.amjcard.2010.03.062","article-title":"Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction","volume":"106","author":"Azab","year":"2010","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib136","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.amjcard.2008.05.006","article-title":"Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome","volume":"102","author":"Tamhane","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2025.104409_bib137","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2147\/JIR.S411086","article-title":"Neutrophil-to-Lymphocyte Ratio and platelet-to-lymphocyte Ratio are important indicators for predicting in-Hospital death in elderly AMI patients","volume":"16","author":"Chen","year":"2023","journal-title":"J Inflamm Res"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib138","doi-asserted-by":"crossref","first-page":"32","DOI":"10.37796\/2211-8039.1425","article-title":"Hematological biomarkers of troponin, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio serve as effective predictive indicators of high-risk mortality in acute coronary syndrome","volume":"13","author":"De Liyis","year":"2023","journal-title":"Biomedicine"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib139","article-title":"Predictive value of neutrophil to lymphocyte ratio and red cell distribution width on death for ST segment elevation myocardial infarction","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104409_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.706852","article-title":"The neutrophil-to-lymphocyte ratio is an important indicator predicting In-Hospital death in AMI patients","volume":"8","author":"Ji","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"21","key":"10.1016\/j.numecd.2025.104409_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39761","article-title":"The neutrophil-to-lymphocyte ratio is associated with in-hospital heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention","volume":"10","author":"Hou","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.numecd.2025.104409_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1275713","article-title":"Association between the neutrophil-to-lymphocyte ratio and risk of in-hospital heart failure and arrhythmia in patients with acute myocardial infarction","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib143","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520959510","article-title":"Correlation of neutrophil-to-lymphocyte ratio with the prognosis of non-ST-segment elevation in patients with acute coronary syndrome undergoing selective percutaneous coronary intervention","volume":"48","author":"Wang","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.numecd.2025.104409_bib144","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/jrms.jrms_485_22","article-title":"The predictive value of neutrophil-lymphocyte ratio combined with the Global Registry of Acute Coronary Events score for inhospital adverse cardiovascular events in patients with acute ST-elevation myocardial infarction","volume":"29","author":"Fang","year":"2024","journal-title":"J Res Med Sci"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023459","article-title":"Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study","volume":"8","author":"Fan","year":"2018","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib146","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4070\/kcj.2013.43.2.93","article-title":"Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in patients with ST-Segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"43","author":"Han","year":"2013","journal-title":"Korean Circ J"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib147","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-096621","article-title":"Predictive value of novel inflammatory markers combined with GRACE score for in-hospital outcome in patients with ST-segment elevation myocardial infarction: a retrospective observational study","volume":"15","author":"Xin","year":"2025","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib148","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/clc.24002","article-title":"Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: a prospective longitudinal study","volume":"46","author":"Wang","year":"2023","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib149","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s40001-025-02804-z","article-title":"Combined prediction value of coronary plaque burden, serum creatinine, MLR and NLR in reinfarction risk after PCI in middle-aged and elderly patients with myocardial infarction","volume":"30","author":"Du","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.numecd.2025.104409_bib150","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.2147\/IJGM.S523100","article-title":"Prediction of first-onset cerebral infarction risk in patients with acute myocardial infarction: a retrospective cohort Study","volume":"18","author":"Zeng","year":"2025","journal-title":"Int J Gen Med"},{"issue":"19","key":"10.1016\/j.numecd.2025.104409_bib151","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e131","article-title":"Neutrophil-to-Lymphocyte Ratio at emergency room predicts mechanical complications of ST-segment elevation myocardial infarction","volume":"36","author":"Yoon","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.numecd.2025.104409_bib152","article-title":"Inflammation-related biomarkers for intracardiac thrombosis in acute myocardial infarction: predictive value and mechanistic implications of NLR and LDL-C","volume":"12","author":"Zhao","year":"2025","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib153","first-page":"171","article-title":"Neutrophil-to-lymphocyte ratio as a predictor of left ventricle function and mortality in patients with myocardial infarction","volume":"21","author":"W\u0119giel","year":"2025","journal-title":"Postepy Kardiol Interwencyjnej"},{"issue":"35","key":"10.1016\/j.numecd.2025.104409_bib154","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039490","article-title":"Effects of platelet-to-lymphocyte ratio on renal function following acute myocardial infarction: a retrospective observational study","volume":"103","author":"Shirasaki","year":"2024","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib155","first-page":"308","article-title":"The association between hemogram parameters and the development of contrast-induced nephropathy in patients presenting with non-ST-elevation myocardial infarction","volume":"4","author":"D\u00f6nmez","year":"2023","journal-title":"Adv Lab Med"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib156","doi-asserted-by":"crossref","DOI":"10.31083\/RCM28167","article-title":"Associations between the platelet lymphocyte ratio and albumin with plaque calcification in patients with acute coronary syndrome: an optical coherence tomography Study","volume":"26","author":"Song","year":"2025","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib157","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12872-025-04730-8","article-title":"Predictive value of peri-coronary fat attenuation index in elderly Non-ST-Elevation myocardial infarction and its correlation with platelet to lymphocyte ratio","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib158","first-page":"288","article-title":"Platelet\/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention","volume":"11","author":"Toprak","year":"2015","journal-title":"Postepy Kardiol Interwencyjnej"},{"issue":"33","key":"10.1016\/j.numecd.2025.104409_bib159","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026942","article-title":"Prognostic value of platelet\/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a prospective observational study","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5152\/akd.2014.5366","article-title":"Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome","volume":"15","author":"Oylumlu","year":"2015","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.numecd.2025.104409_bib161","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.948334","article-title":"Platelet-to-Lymphocyte Ratio as a predictor of atrial fibrillation in STEMI patients","volume":"31","author":"Li","year":"2025","journal-title":"Med Sci Monit"},{"issue":"7","key":"10.1016\/j.numecd.2025.104409_bib162","article-title":"Utility of C-reactive protein-to-albumin and uric acid-to-albumin ratios for assessing coronary artery disease severity in acute coronary syndrome: a Study from a major tertiary care Center in Northeast India","volume":"17","author":"Prasad","year":"2025","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.numecd.2025.104409_bib163","article-title":"Correlation between the C-reactive protein-to-albumin ratio and severity of coronary artery disease in patients with myocardial infarction","volume":"17","author":"Hakak","year":"2025","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib164","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.repc.2018.08.008","article-title":"Assessment of the relationship between preprocedural C-reactive protein\/albumin ratio and stent restenosis in patients with ST-segment elevation myocardial infarction","volume":"38","author":"Rencuzogullari","year":"2019","journal-title":"Rev Port Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22848","article-title":"The association between CRP\/Albumin ratio and in-stent restenosis development in patients with ST-segment elevation myocardial infarction","volume":"33","author":"Aksu","year":"2019","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2024.0867","article-title":"Assessment of the relationship between C-Reactive protein-to-albumin ratio and culprit lesion location in patients with ST-Segment elevation myocardial infarction","volume":"86","author":"Deng","year":"2025","journal-title":"Br J Hosp Med"},{"issue":"10","key":"10.1016\/j.numecd.2025.104409_bib167","article-title":"The relationship between C-reactive protein albumin ratio and long-term mortality in patients with acute coronary syndrome","volume":"15","author":"Birdal","year":"2023","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib168","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3906\/sag-2003-188","article-title":"Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction","volume":"51","author":"S\u00f6\u011f\u00fct","year":"2021","journal-title":"Turk J Med Sci"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib169","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4274\/imj.galenos.2021.53806","article-title":"C-Reactive protein and albumin ratio predicts mortality in elderly patients aged eighty years and over with Non-ST-Segment elevation myocardial infarction","volume":"22","author":"\u015eim\u015fek","year":"2021","journal-title":"Istanbul Med J"},{"issue":"33197251322935","key":"10.1016\/j.numecd.2025.104409_bib170","article-title":"Hs-CRP\/ALB levels are associated with poor long-term prognosis in patients with STEMI undergoing percutaneous coronary intervention","volume":"27","author":"Li","year":"2025","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib171","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12944-025-02707-2","article-title":"Integrated metabolic-inflammatory risk assessment: HbA1c\/HDL-c and hsCRP-to-albumin ratios synergistically predict major adverse cardiovascular events in post-PCI STEMI patients","volume":"24","author":"Huang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2025.104409_bib172","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.946897","article-title":"Relationship between CRP\/ALB ratio and severity of coronary artery lesions in hypertensive patients with acute myocardial infarction","volume":"31","author":"Lou","year":"2025","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.numecd.2025.104409_bib173","doi-asserted-by":"crossref","unstructured":"Mathi M, Ramadurai S, Mani R, et al. (August 28, 2025) comparative performance of the C-reactive Protein-to-Albumin Ratio (CAR) and the Thrombolysis in Myocardial Infarction (TIMI) Score in predicting Major Adverse Cardiac Events (MACE) among patients with ST-Elevation Myocardial Infarction (STEMI). Cureus 17(8): e91175. doi:10.7759\/cureus.91175.","DOI":"10.7759\/cureus.91175"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib174","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0003319720963697","article-title":"Predictive value of C-Reactive protein to albumin ratio in ST-Segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention","volume":"72","author":"Acet","year":"2021","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib175","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/0003319719898057","article-title":"Value of C-Reactive Protein\/Albumin ratio in predicting the development of contrast-induced nephropathy in patients with Non-ST elevation myocardial infarction","volume":"71","author":"Satilmis","year":"2020","journal-title":"Angiology"},{"key":"10.1016\/j.numecd.2025.104409_bib176","article-title":"Predictive value of crp\/albumin ratio for in-hospital atrial fibrillation development in st segment elevation myocardial infarction","volume":"1","author":"Kalkan","year":"2019","journal-title":"Annals of Medical Research"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib177","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2025.104409_bib178","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"29","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2025.104409_bib179","article-title":"Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement","volume":"10","author":"Tognola","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.numecd.2025.104409_bib180","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41440-023-01472-y","article-title":"White blood cell and platelet distribution widths are associated with hypertension: data mining approaches","volume":"47","author":"Mansoori","year":"2024","journal-title":"Hypertens Res"},{"issue":"12","key":"10.1016\/j.numecd.2025.104409_bib181","first-page":"938","article-title":"Terapie antinfiammatorie in pazienti con malattie cardiovascolari: nuove evidenze, implicazioni cliniche e prospettive [Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives]","volume":"23","author":"Gragnano","year":"2022","journal-title":"G Ital Cardiol"},{"issue":"21","key":"10.1016\/j.numecd.2025.104409_bib182","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib183","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3390\/nu15061517","article-title":"Anti-Inflammatory effects of lipid-lowering drugs and Supplements-A narrative review","volume":"15","author":"Zivkovic","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.numecd.2025.104409_bib184","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/metabo14070388","article-title":"The pleiotropic effects of lipid-modifying interventions: exploring traditional and emerging hypolipidemic therapies","volume":"14","author":"Kounatidis","year":"2024","journal-title":"Metabolites"},{"issue":"34","key":"10.1016\/j.numecd.2025.104409_bib185","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"38","key":"10.1016\/j.numecd.2025.104409_bib186","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"26","key":"10.1016\/j.numecd.2025.104409_bib187","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104409_bib188","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.numecd.2025.104409_bib189","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"CANTOS trial group. Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104409_bib190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2019.06.003","article-title":"The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: a pilot randomized placebo controlled trial of colchicine following acute myocardial infarction","volume":"215","author":"Hennessy","year":"2019","journal-title":"Am Heart J"},{"issue":"20","key":"10.1016\/j.numecd.2025.104409_bib191","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the Australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib192","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12872-021-02393-9","article-title":"Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial","volume":"21","author":"Akrami","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"10.1016\/j.numecd.2025.104409_bib193","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib194","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002474","article-title":"Colchicine in acute myocardial infarction: cardiovascular events at 1-year follow up","volume":"11","author":"Bouleti","year":"2024","journal-title":"Open Heart"},{"issue":"4","key":"10.1016\/j.numecd.2025.104409_bib195","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/FJC.0000000000001317","article-title":"Preprocedural colchicine in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial (PodCAST-PCI)","volume":"80","author":"Hosseini","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.numecd.2025.104409_bib196","article-title":"Colchicine in acute myocardial infarction","volume":"17","author":"Jolly","year":"2024","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.numecd.2025.104409_bib197","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-V","article-title":"Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty","volume":"19","author":"O'Keefe","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.numecd.2025.104409_bib198","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0002-9149(99)80334-8","article-title":"Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty","volume":"76","author":"Freed","year":"1995","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.numecd.2025.104409_bib199","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-Inflammatory treatment with colchicine in acute myocardial infarction: a pilot Study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib200","first-page":"11","article-title":"Role of colchicine in reducing reperfusion injury in STEMI patients who undergo primary percutaneous coronary intervention: a randomized clinical trial","volume":"57","author":"Karim","year":"2025","journal-title":"Acta Med Indones"},{"issue":"5","key":"10.1016\/j.numecd.2025.104409_bib201","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009992","article-title":"Colchicine to prevent periprocedural myocardial injury in percutaneous coronary intervention: the COPE-PCI pilot trial","volume":"14","author":"Cole","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cvr\/cvae191","article-title":"Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction","volume":"121","author":"Psaltis","year":"2025","journal-title":"Cardiovasc Res"},{"issue":"13","key":"10.1016\/j.numecd.2025.104409_bib203","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial","volume":"150","author":"Yu","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2025.104409_bib204","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2014.04.009","article-title":"Colchicine effect on P-glycoprotein expression and activity: in silico and in vitro studies","volume":"218","author":"Silva","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.numecd.2025.104409_bib205","series-title":"Hunter's tropical medicine and emerging infectious disease","first-page":"923","article-title":"Poisonous plants and aquatic animals: poisonous aquatic animals","author":"Warrell","year":"2012"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib206","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease","volume":"135","author":"Robinson","year":"2022","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib207","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semarthrit.2020.11.007","article-title":"A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections","volume":"51","author":"McEwan","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.numecd.2025.104409_bib208","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/heartjnl-2015-308542","article-title":"Cardiovascular effects and safety of long-term colchicine treatment: cochrane review and meta-analysis","volume":"102","author":"Hemkens","year":"2016","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.numecd.2025.104409_bib209","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1586\/1744666X.2014.880653","article-title":"Canakinumab for gout: a specific, patient-profiled indication","volume":"10","author":"Perez-Ruiz","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"10.1016\/j.numecd.2025.104409_bib210","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/14712598.2016.1233963","article-title":"Canakinumab investigated for treating familial Mediterranean fever","volume":"16","author":"Haviv","year":"2016","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.numecd.2025.104409_bib211","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FJC.0000000000000839","article-title":"Anakinra in recurrent pericarditis: current evidence on clinical use, effectiveness, and safety","volume":"76","author":"Correia","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"issue":"15","key":"10.1016\/j.numecd.2025.104409_bib212","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-Segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.numecd.2025.104409_bib213","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/ehu272","article-title":"The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study","volume":"36","author":"Morton","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2025.104409_bib214","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ahj.2016.06.003","article-title":"Rationale and design of the Randomized Evaluation of patients with stable angina Comparing Utilization of noninvasive Examinations (RESCUE) trial","volume":"179","author":"Stillman","year":"2016","journal-title":"Am Heart J"},{"issue":"24","key":"10.1016\/j.numecd.2025.104409_bib215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413471","article-title":"Inflammation in coronary microvascular dysfunction","volume":"22","author":"Sagris","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.numecd.2025.104409_bib216","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-Dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325005642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325005642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:22:14Z","timestamp":1769170934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325005642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":216,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0939475325005642"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104409","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"104409"}}